Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics (2016)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; TOZATTO, EDUARDO - FCFRP ; DONADI, EDUARDO ANTONIO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.jpba.2015.12.009
- Subjects: MOLÉCULA; ANTI-INFLAMATÓRIOS; FARMACOCINÉTICA; PLASMA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Pharmaceutical and Biomedical Analysis
- ISSN: 0731-7085
- Volume/Número/Paginação/Ano: v. 120, p. 120-126, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Carolina de Miranda et al. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, v. 120, p. 120-126, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2015.12.009. Acesso em: 28 dez. 2025. -
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., & Lanchote, V. L. (2016). Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, 120, 120-126. doi:10.1016/j.jpba.2015.12.009 -
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Lanchote VL. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 120 120-126.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.jpba.2015.12.009 -
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Lanchote VL. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 120 120-126.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.jpba.2015.12.009 - Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac
- Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A
- Factors influencing plasma concentrations of carbamazepine, carbama zepine-10,11-epoxide and carbamazepine-10,11-dihydroxy in epileptic children
- A highly sensitive lc-ms-ms assay for analysis of ciclophosphamide enantiomers in plasma: applications to pharmacokinetics in lupus nephritis patients
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- Desenvolvimento de metodologia analítica por cromatografia gasosa para determinação do teor de cafeína em sementes de guaraná (Paullinia cupana)
- Estereosseletividade na farmacocinética da Fluvastatina em pacientes diabéticos-hipercolesterolêmicos
- Stereoselective pharmacokinetics of lercanidipine by liquid chromatography tandem mass spectrometry
- Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Stereoselective disposition of fenoprofen in plasma and synovial fluid of patients with rheumathoid arthritis
Informações sobre o DOI: 10.1016/j.jpba.2015.12.009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
